These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
415 related items for PubMed ID: 34392977
1. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors? Safi SA, Rehders A, Haeberle L, Fung S, Lehwald N, Esposito I, Ziayee F, Krieg A, Knoefel WT, Fluegen G. Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977 [Abstract] [Full Text] [Related]
2. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer. Sperti C, Gruppo M, Blandamura S, Valmasoni M, Pozza G, Passuello N, Beltrame V, Moletta L. World J Gastroenterol; 2017 Jun 28; 23(24):4399-4406. PubMed ID: 28706422 [Abstract] [Full Text] [Related]
3. Para-aortic lymph node sampling in pancreatic head adenocarcinoma. Schwarz L, Lupinacci RM, Svrcek M, Lesurtel M, Bubenheim M, Vuarnesson H, Balladur P, Paye F. Br J Surg; 2014 Apr 28; 101(5):530-8. PubMed ID: 24633831 [Abstract] [Full Text] [Related]
4. Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report. Masui T, Kubota T, Aoki K, Nakanishi Y, Miyamoto T, Nagata J, Morino K, Fukugaki A, Takamura M, Sugimoto S, Onuma H, Tokuka A. World J Surg Oncol; 2013 Aug 14; 11(1):195. PubMed ID: 23945441 [Abstract] [Full Text] [Related]
5. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Yuasa Y, Sueda T. World J Surg; 2010 Aug 14; 34(8):1900-7. PubMed ID: 20376442 [Abstract] [Full Text] [Related]
6. Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer? Liu C, Lu Y, Luo G, Cheng H, Guo M, Liu Z, Xu J, Long J, Liu L, Fu D, Ni Q, Li M, Yu X. Oncotarget; 2016 May 17; 7(20):29177-86. PubMed ID: 27081079 [Abstract] [Full Text] [Related]
7. Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma. Hirono S, Kawai M, Okada KI, Miyazawa M, Kitahata Y, Kobayashi R, Hayami S, Ueno M, Yamaue H. Eur J Surg Oncol; 2021 Oct 17; 47(10):2586-2594. PubMed ID: 34127329 [Abstract] [Full Text] [Related]
8. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study. Kuesters S, Chikhladze S, Makowiec F, Sick O, Fichtner-Feigl S, Hopt UT, Wittel UA. Int J Surg; 2018 Jul 17; 55():162-166. PubMed ID: 29807171 [Abstract] [Full Text] [Related]
9. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Klöppel G, Dhaene K, Michelassi F. Ann Surg; 1998 Oct 17; 228(4):508-17. PubMed ID: 9790340 [Abstract] [Full Text] [Related]
10. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations. Meriggi F, Gramigna P, Forni E. Hepatogastroenterology; 2007 Mar 17; 54(74):549-55. PubMed ID: 17523320 [Abstract] [Full Text] [Related]
11. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival. Kuo S, Ventin M, Sato H, Harrison JM, Okuda Y, Qadan M, Ferrone CR, Lillemoe KD, Fernandez-Del Castillo C. J Gastrointest Surg; 2024 May 17; 28(5):672-678. PubMed ID: 38704205 [Abstract] [Full Text] [Related]
12. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Sanjay P, de Figueiredo RS, Leaver H, Ogston S, Kulli C, Polignano FM, Tait IS. JOP; 2012 Mar 10; 13(2):199-204. PubMed ID: 22406601 [Abstract] [Full Text] [Related]
13. CA19-9 level determines therapeutic modality in pancreatic cancer patients with para-aortic lymph node metastasis. Asaoka T, Miyamoto A, Maeda S, Hama N, Tsujie M, Ikeda M, Sekimoto M, Nakamori S. Hepatobiliary Pancreat Dis Int; 2018 Feb 10; 17(1):75-80. PubMed ID: 29428109 [Abstract] [Full Text] [Related]
14. Preoperative risk factors for para-aortic lymph node positivity in pancreatic cancer. Okada K, Uemura K, Kondo N, Sumiyoshi T, Seo S, Otsuka H, Serikawa M, Ishii Y, Tsuboi T, Murakami Y, Takahashi S. Pancreatology; 2021 Apr 10; 21(3):606-612. PubMed ID: 33648880 [Abstract] [Full Text] [Related]
15. Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma. Fastrez M, Goffin F, Vergote I, Vandromme J, Petit P, Leunen K, Degueldre M. Acta Obstet Gynecol Scand; 2013 Aug 10; 92(8):895-901. PubMed ID: 23590725 [Abstract] [Full Text] [Related]
16. Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer. Doi R, Kami K, Ito D, Fujimoto K, Kawaguchi Y, Wada M, Kogire M, Hosotani R, Imamura M, Uemoto S. World J Surg; 2007 Jan 10; 31(1):147-54. PubMed ID: 17171496 [Abstract] [Full Text] [Related]
18. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head. Wu C, Hou SZ, Wu Z, Huang X, Wang Z, Tian B. BMC Cancer; 2021 May 27; 21(1):624. PubMed ID: 34044806 [Abstract] [Full Text] [Related]
19. Survival advantage with para aortic lymphadenectomy in peri-ampullary cancer: A retrospective cohort study. Hafeez Bhatti AB, Dar FS, Sahaab E, Khan NY, Zia H, Rana A, Salih M, Shah NH. Int J Surg; 2016 Jul 27; 31():58-62. PubMed ID: 27262530 [Abstract] [Full Text] [Related]